PCN6 the Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

Value in Health- United Kingdom

doi 10.1016/j.jval.2012.08.1201

Full Text

Abstract

Available in

Categories

Occupational Health

Date

November 1, 2012

Authors

C. Uyl-de Groot

Publisher

Elsevier BV

Related search

A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma

Journal of immunotherapy (Hagerstown, Md. : 1997)

Cancer Research

English

Pcn6 - Systematic Literature Review of Efficacy & Safety Data for the Treatment of Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma

Value in Health

Occupational Health

English

Disparities in the Treatment of Patients With IL-2 for Metastatic Renal Cell Carcinoma

Urologic Oncology: Seminars and Original Investigations

English

The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

The Bevacizumab Experience in Advanced Renal Cell Carcinoma

OncoTargets and Therapy

English

Prognosis of Patients With Metastatic Renal Cell Carcinoma and Pancreatic Metastases

BJU International

English

Axitinib for the Management of Metastatic Renal Cell Carcinoma

Drugs in R and D

English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy

English

Pcn165 - Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review

Value in Health

Occupational Health

English